Bioventus
BVS • NASDAQ
Bioventus is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Robert E. Claypoole, with a market cap of $613.0M.
Market Cap$613.0M
Employees995.0
CEORobert E. Claypoole
CountryUnited States of America
Healthcare
Medical - Devices
Next EarningsMay 5, 2026 · In 3 weeksQ1 2026
Financials
Bioventus FAQ
Common questions about Bioventus
Bioventus is scheduled to report earnings for Q1 2026 on May 5, 2026. Analysts estimate revenue of $129.8M.
Bioventus has approximately 995 employees.